Beam Therapeutics (BEAM) Operating Income (2019 - 2026)
Beam Therapeutics (BEAM) reported Operating Income of -$107.2 million for Q1 2026, up 10.12% year-over-year from -$97.4 million in Q1 2025, and down 514.59% quarter-over-quarter from -$17.4 million in Q4 2025.
Beam Therapeutics (BEAM) Operating Income (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has 8 years of Operating Income data on file, last reported at -$107.2 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$107.2 million, up 10.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$371.6 million (up 13.72% YoY), and the FY2025 annual result was -$383.7 million, up 7.67% from the prior year.
- Operating Income fell to -$107.2 million in Q1 2026 per BEAM's latest filing, from -$17.4 million in the prior quarter.
- Over five years, Operating Income peaked at $132.9 million in Q4 2023 and troughed at -$126.8 million in Q3 2025.
- A 5-year average of -$83.6 million and a median of -$102.1 million in 2023 frame the typical range for Operating Income.
- The sharpest annual moves came in 2023 and 2024: Operating Income jumped 249.3% in 2023, then tumbled 175.3% in 2024.
- A 5-year view of Operating Income shows it stood at -$89.0 million in 2022, then jumped by 249.3% to $132.9 million in 2023, then plunged by 175.3% to -$100.0 million in 2024, then surged by 82.56% to -$17.4 million in 2025, then sank by 514.59% to -$107.2 million in 2026.
- Business Quant data shows BEAM's Operating Income at -$107.2 million in Q1 2026, -$17.4 million in Q4 2025, and -$126.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Beam Therapeutics | 3.53 Bn | 3.53 Bn | - | -107.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.22 Mn |
| Dec 31, 2025 | -17.45 Mn |
| Sep 30, 2025 | -126.81 Mn |
| Jun 30, 2025 | -120.15 Mn |
| Mar 31, 2025 | -119.29 Mn |
| Dec 31, 2024 | -100.04 Mn |
| Sep 30, 2024 | -106.50 Mn |
| Jun 30, 2024 | -104.90 Mn |
| Mar 31, 2024 | -104.13 Mn |
| Dec 31, 2023 | 132.86 Mn |
| Sep 30, 2023 | -108.27 Mn |
| Jun 30, 2023 | -102.15 Mn |
| Mar 31, 2023 | -98.93 Mn |
| Dec 31, 2022 | -88.99 Mn |
| Sep 30, 2022 | -91.30 Mn |
| Jun 30, 2022 | -81.97 Mn |
| Mar 31, 2022 | -76.23 Mn |
| Dec 31, 2021 | -63.48 Mn |
| Sep 30, 2021 | -69.63 Mn |
| Jun 30, 2021 | -58.97 Mn |